User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure

Primary tabs

download
  • Open access
  • PDF
  • 0.96 M
Gruson, Damien [UCL] Ferracin, Benjamin [UCL] Ahn, Sylvie A. [UCL] Zierold, Claudia Blocki, Frank Rousseau, Michel [UCL] Passino, Claudio

Objectives: Vitamin D deficiency and hyperparathyroidism are common in patients with heart failure (HF). There is a growing body of evidence supporting the role of vitamin D and parathyroid hormone (PTH) in cardiac remodeling and worsening of HF. Lack of reliable automated testing of 1,25-dihydroxyvitamin D (1,25(OH)2D), the biologically active metabolite of vitamin D, has limited its contribution to the prognostic assessment of HF. Here, the association of 1,25(OH)2D and PTH(1–84) levels was evaluated for prediction of cardiovascular death in chronic HF patients. Methods: We conducted a single center prospective cohort including 170 chronic HF patients (females n = 36; males n = 134; NYHA II-IV; mean age: 67 years; etiology: ischemic n = 119, dilated cardiomyopathy n = 51; mean LVEF: 23%). The primary outcome was cardiovascular death. Results: Serum levels of 1,25(OH)2D decreased markedly with increased HF severity. Medians were 33.3 pg/mL for NYHA-II patients, 23.4 pg/mL for NYHA-III, and 14.0 pg/mL for NYHA-IV patients (p<0.001). Most patients had levels of 25(OH)D below 30ng/mL, and stratification by NYHA functional class did not show significant differences (p = 0.249). The 1,25(OH)2D to PTH(1–84) ratio and the (1,25(OH)2D)2 to PTH(1–84) ratio were found to be the most significantly related to HF severity. After a median follow-up of 4.1 years, 106 out of 170 patients reached the primary endpoint. Cox proportional hazard modeling revealed 1,25(OH)2D and the 1,25(OH)2D to PTH(1–84) ratios to be strongly predictive of outcomes. Conclusions: 1,25(OH)2D and its ratios to PTH(1–84) strongly and independently predict cardiovascular mortality in chronic HF.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2015
Language Anglais
Journal information "PLoS One" - Vol. 10, no. 8, p. e0135427 [1-15] (2015)
Peer reviewed yes
Publisher Public Library of Science ((United States) San Francisco, CA)
e-issn 1932-6203
Publication status Publié
Affiliations UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition
UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCL - (SLuc) Service de biochimie médicale
UCL - (SLuc) Service de cardiologie
Links
  1. Nichols Melanie, Townsend Nick, Scarborough Peter, Rayner Mike, Cardiovascular disease in Europe 2014: epidemiological update, 10.1093/eurheartj/ehu299
  2. LC Liu, Eur J Heart Fail, 16, 122 (2014)
  3. E Braunwald, Circulation, 102, IV14 (2000)
  4. CW Yancy, J Am Coll Cardiol, 10 (2013)
  5. Januzzi James L., Chen-Tournoux Annabel A., Moe Gordon, Amino-Terminal Pro–B-Type Natriuretic Peptide Testing for the Diagnosis or Exclusion of Heart Failure in Patients with Acute Symptoms, 10.1016/j.amjcard.2007.11.017
  6. M Nichols, Eur Heart J (2014)
  7. Mueller Christian, Cost-Effectiveness of B-Type Natriuretic Peptide Testing, 10.1111/j.1751-7133.2008.08312.x
  8. Roubille François, Delseny Delphine, Cristol Jean-Paul, Merle Delphine, Salvetat Nicolas, Larue Catherine, Davy Jean-Marc, Leclercq Florence, Pasquie Jean-Luc, Guerrier Luc, Fareh Jeannette, Dupuy Anne-Marie, Depletion of proBNP1-108 in Patients with Heart Failure Prevents Cross-Reactivity with Natriuretic Peptides, 10.1371/journal.pone.0075174
  9. Savarese Gianluigi, Trimarco Bruno, Dellegrottaglie Santo, Prastaro Maria, Gambardella Francesco, Rengo Giuseppe, Leosco Dario, Perrone-Filardi Pasquale, Natriuretic Peptide-Guided Therapy in Chronic Heart Failure: A Meta-Analysis of 2,686 Patients in 12 Randomized Trials, 10.1371/journal.pone.0058287
  10. Maisel Alan, Mueller Christian, Adams Kirkwood, Anker Stefan D., Aspromonte Nadia, Cleland John G.F., Cohen-Solal Alain, Dahlstrom Ulf, DeMaria Anthony, Di Somma Salvatore, Filippatos Gerasimos S., Fonarow Gregg C., Jourdain Patrick, Komajda Michel, Liu Peter P., McDonagh Theresa, McDonald Kenneth, Mebazaa Alexandre, Nieminen Markku S., Peacock W. Frank, Tubaro Marco, Valle Roberto, Vanderhyden Marc, Yancy Clyde W., Zannad Faiez, Braunwald Eugene, State of the art: Using natriuretic peptide levels in clinical practice, 10.1016/j.ejheart.2008.07.014
  11. Emdin Michele, Vittorini Simona, Passino Claudio, Clerico Aldo, Old and new biomarkers of heart failure, 10.1093/eurjhf/hfp035
  12. M Volpe, Eur Heart J (2013)
  13. de Boer Rudolf A., Lok Dirk J. A., Jaarsma Tiny, van der Meer Peter, Voors Adriaan A., Hillege Hans L., van Veldhuisen Dirk J., Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction, 10.3109/07853890.2010.538080
  14. Gruson D., Buglioni A., Burnett J.C., PTH: Potential role in management of heart failure, 10.1016/j.cca.2014.03.029
  15. Tuñón José, Cristóbal Carmen, Tarín Nieves, Aceña Álvaro, González-Casaus María Luisa, Huelmos Ana, Alonso Joaquín, Lorenzo Óscar, González-Parra Emilio, Mahíllo-Fernández Ignacio, Pello Ana María, Carda Rocío, Farré Jerónimo, Rodríguez-Artalejo Fernando, López-Bescós Lorenzo, Egido Jesús, Coexistence of Low Vitamin D and High Fibroblast Growth Factor-23 Plasma Levels Predicts an Adverse Outcome in Patients with Coronary Artery Disease, 10.1371/journal.pone.0095402
  16. Schierbeck Louise Lind, Jensen Torben Slott, Bang Ulrich, Jensen Gorm, Køber Lars, Jensen Jens-Erik Beck, Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure, 10.1093/eurjhf/hfr016
  17. Wang T. J., Pencina M. J., Booth S. L., Jacques P. F., Ingelsson E., Lanier K., Benjamin E. J., D'Agostino R. B., Wolf M., Vasan R. S., Vitamin D Deficiency and Risk of Cardiovascular Disease, 10.1161/circulationaha.107.706127
  18. Tomaschitz A., Ritz E., Pieske B., Fahrleitner-Pammer A., Kienreich K., Horina J. H., Drechsler C., Marz W., Ofner M., Pieber T. R., Pilz S., Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease, 10.1093/cvr/cvs092
  19. Silver J., Rodriguez M., Slatopolsky E., FGF23 and PTH--double agents at the heart of CKD, 10.1093/ndt/gfs050
  20. Udell Jacob A., Morrow David A., Jarolim Petr, Sloan Sarah, Hoffman Elaine B., O'Donnell Thomas F., Vora Amit N., Omland Torbjørn, Solomon Scott D., Pfeffer Marc A., Braunwald Eugene, Sabatine Marc S., Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease, 10.1016/j.jacc.2014.03.026
  21. Scialla Julia J., Wolf Myles, Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease, 10.1038/nrneph.2014.49
  22. HJ van, Clin Chem Lab Med (2014)
  23. Renkema Kirsten Y., Alexander R. Todd, Bindels René J., Hoenderop Joost G., Calcium and phosphate homeostasis: Concerted interplay of new regulators, 10.1080/07853890701689645
  24. CA Keyzer, J Clin Endocrinol Metab (2014)
  25. Zittermann A., Schleithoff S. S., Frisch S., Gotting C., Kuhn J., Koertke H., Kleesiek K., Tenderich G., Koerfer R., Circulating Calcitriol Concentrations and Total Mortality, 10.1373/clinchem.2008.120006
  26. Adams John S., Hewison Martin, Update in Vitamin D, 10.1210/jc.2009-1773
  27. Zittermann Armin, Schleithoff Stefanie S., Götting Christian, Dronow Oxana, Fuchs Uwe, Kuhn Joachim, Kleesiek Knut, Tenderich Gero, Koerfer Reiner, Poor outcome in end-stage heart failure patients with low circulating calcitriol levels, 10.1016/j.ejheart.2008.01.013
  28. Gotsman Israel, Shauer Ayelet, Zwas Donna R., Hellman Yaron, Keren Andre, Lotan Chaim, Admon Dan, Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome, 10.1093/eurjhf/hfr175
  29. Wannamethee S. G., Welsh P., Papacosta O., Lennon L., Whincup P. H., Sattar N., Elevated Parathyroid Hormone, But Not Vitamin D Deficiency, Is Associated With Increased Risk of Heart Failure in Older Men With and Without Cardiovascular Disease, 10.1161/circheartfailure.114.001272
  30. di Giuseppe Romina, Buijsse Brian, Hirche Frank, Wirth Janine, Arregui Maria, Westphal Sabine, Isermann Berend, Hense Hans W., Dierkes Jutta, Boeing Heiner, Stangl Gabriele I., Weikert Cornelia, Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study, 10.1210/jc.2013-2963
  31. Eknoyan G., Adolphe Quetelet (1796 1874) the average man and indices of obesity, 10.1093/ndt/gfm517
  32. Gruson D., Lepoutre T., Ahn S.A., Ketelslegers J.M., Rousseau M.F., Comparison between intact and bioactive parathyroid hormone assays in patients with severe heart failure, 10.1016/j.clinbiochem.2012.12.002
  33. Altay Hakan, Zorlu Ali, Binici Suleyman, Bilgi Muhammet, Yilmaz Mehmet Birhan, Colkesen Yucel, Erol Tansel, Muderrisoglu Haldun, Relation of Serum Parathyroid Hormone Level to Severity of Heart Failure, 10.1016/j.amjcard.2011.08.039
  34. Khouzam Rami N., Weber Karl T., Flax Sherri D., Dishmon Dwight A., Farah Victor, Carbone Laura D., Secondary Hyperparathyroidism in Patients with Untreated and Treated Congestive Heart Failure, 10.1097/00000441-200601000-00009
  35. D Gruson, J Endocrinol Invest, 35, 987 (2012)
  36. Saleh F, Parathyroid hormone and left ventricular hypertrophy, 10.1016/j.ehj.2003.09.010
  37. Chhokar V. S., Hyperparathyroidism and the Calcium Paradox of Aldosteronism, 10.1161/01.cir.0000155621.10213.06
  38. Rutledge Michael R., Farah Victor, Adeboye Adedayo A., Seawell Michael R., Bhattacharya Syamal K., Weber Karl T., Parathyroid Hormone, A Crucial Mediator of Pathologic Cardiac Remodeling in Aldosteronism, 10.1007/s10557-012-6378-0
  39. Vidal A., Calcium paradox of aldosteronism and the role of the parathyroid glands, 10.1152/ajpheart.00535.2005
  40. Lysaght Andrew C., Yuan Quan, Fan Yi, Kalwani Neil, Caruso Paul, Cunnane MaryBeth, Lanske Beate, Stanković Konstantina M., FGF23 Deficiency Leads to Mixed Hearing Loss and Middle Ear Malformation in Mice, 10.1371/journal.pone.0107681
  41. Razzaque M. Shawkat, The FGF23–Klotho axis: endocrine regulation of phosphate homeostasis, 10.1038/nrendo.2009.196
  42. J Bernheim, Nephrol Dial Transplant (2011)
  43. Parker Benjamin D., The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study, 10.7326/0003-4819-152-10-201005180-00004
  44. Gutierrez O. M., Januzzi J. L., Isakova T., Laliberte K., Smith K., Collerone G., Sarwar A., Hoffmann U., Coglianese E., Christenson R., Wang T. J., deFilippi C., Wolf M., Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease, 10.1161/circulationaha.108.844506
  45. Gruson Damien, Lepoutre Thibault, Ketelslegers Jean-Marie, Cumps Jean, Ahn Sylvie A., Rousseau Michel F., C-terminal FGF23 is a strong predictor of survival in systolic heart failure, 10.1016/j.peptides.2012.08.003
  46. Liu Shiguang, Guo Rong, Simpson Leigh G., Xiao Zhou-Sheng, Burnham Charles E., Quarles L. Darryl, Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX, 10.1074/jbc.m304544200
  47. Li G., Oparil S., Kelpke S. S., Chen Y.-F., Thompson J. A., Fibroblast Growth Factor Receptor-1 Signaling Induces Osteopontin Expression and Vascular Smooth Muscle Cell-Dependent Adventitial Fibroblast Migration In Vitro, 10.1161/01.cir.0000024113.26985.cc
  48. Yoo Seung Hyun, Huh Yang Hoon, Hur Yong Suk, Inositol 1,4,5-Trisphosphate Receptor in Chromaffin Secretory Granules and Its Relation to Chromogranins, 10.1007/s10571-010-9564-2
  49. D'amico M. A., Ghinassi B., Izzicupo P., Manzoli L., Di Baldassarre A., Biological function and clinical relevance of chromogranin A and derived peptides, 10.1530/ec-14-0027
  50. Angelone T., Mazza R., C. Cerra M., Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease, 10.2174/092986712802430009
  51. C Wu, Eur J Heart Fail (2012)
  52. Wang Lingling, Yuan Tao, Du Guoli, Zhao Qiying, Ma Lijuan, Zhu Jun, The impact of 1,25-dihydroxyvitamin D3 on the expression of connective tissue growth factor and transforming growth factor-β1 in the myocardium of rats with diabetes, 10.1016/j.diabres.2014.01.031
  53. Dong Jinghui, Wong Siu Ling, Lau Chi Wai, Lee Hung Kay, Ng Chi Fai, Zhang Lihong, Yao Xiaoqiang, Chen Zhen Yu, Vanhoutte Paul M., Huang Yu, Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress, 10.1093/eurheartj/ehr459
  54. Lemmilä Satu, Saha Heikki, Virtanen Vesa, Ala-Houhala Ilpo, Pasternack Amos, Effect of Intravenous Calcitriol on Cardiac Systolic and Diastolic Function in Patients on Hemodialysis, 10.1159/000013384
  55. Selektor Yelena, Sun Yao, Weber Karl T., Gerling Ivan C., Ahokas Robert A., Bhattacharya Syamal K., Cinacalcet and the Prevention of Secondary Hyperparathyroidism in Rats With Aldosteronism, 10.1097/maj.0b013e318134f013
  56. Carbone Laura D., Cross Jessica D., Raza Syed H., Bush Andrew J., Sepanski Robert J., Dhawan Saurabh, Khan Bilal Q., Gupta Malini, Ahmad Khurram, Khouzam Rami N., Dishmon Dwight A., Nesheiwat Joseph P., Hajjar Mohammad A., Chishti Waqas A., Nasser Wael, Khan Mehwish, Womack Catherine R., Cho Tara, Haskin Ashley R., Weber Karl T., Fracture Risk in Men With Congestive Heart Failure, 10.1016/j.jacc.2008.03.039
Bibliographic reference Gruson, Damien ; Ferracin, Benjamin ; Ahn, Sylvie A. ; Zierold, Claudia ; Blocki, Frank ; et. al. 1,25-Dihydroxyvitamin D to PTH(1–84) Ratios Strongly Predict Cardiovascular Death in Heart Failure. In: PLoS One, Vol. 10, no. 8, p. e0135427 [1-15] (2015)
Permanent URL http://hdl.handle.net/2078.1/186280